Tryfonidis K, Zardavas D, Katzenellenbogen BS, Piccart M
Bowker SL, Majumdar SR, Veugelers P, et al
Reconstituted ipamorelin loses potency through oxidation, aggregation, and thermal unfolding at rates doubling every 10C above 8C, with complete activity loss possible within hours at room temperature
IV therapy may be part of a wellness plan, but it should not replace finding out why symptoms are happening
He adds that during the Surmount-1 trial, 50% of patients lost over 20% of their total weight, compared to 32% of patients losing the same amount of weight from semaglutide in the Step 1 trial